Point72 Hong Kong LTD Immunocore Holdings PLC Call Options Transaction History
Point72 Hong Kong LTD
- $1.34 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
145Shares Held
44.6MCall Options Held
267KPut Options Held
1.16M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$247 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$170 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$147 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$132 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$85.5 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.54B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...